{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T07:08:22Z","timestamp":1769497702511,"version":"3.49.0"},"reference-count":0,"publisher":"Hogrefe Publishing Group","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Praxis"],"published-print":{"date-parts":[[2002,1,1]]},"abstract":"<jats:p> Le nombre de m\u00e9ningoenc\u00e9phalites printani\u00e8res (FSME) a augment\u00e9 en Suisse durant ces derni\u00e8res ann\u00e9es et les territoires d'end\u00e9mie du virus de la FSME s'\u00e9tendent. Comme cette FSME peut \u00eatre potentiellement dangereuse, une immunisation active prend toujours plus d'importance. La connaissance du spectre des effets secondaires du vaccin est tr\u00e8s importante pour \u00e9valuer son rapport co\u00fbt\/risque. La Centrale Suisse des Effets Secondaires des M\u00e9dicaments a re\u00e7u depuis 1987 jusqu'en juin 2000 33 annonces de telles complications avec 39 perturbations neurologiques chez lesquels un lien de causalit\u00e9 avec une vaccination contre la FSME \u00e9tait possible. Le probl\u00e8me le plus fr\u00e9quent \u00e9tait des maux de t\u00eate (36%) puis des neuropathies (18%) et des irritations m\u00e9ning\u00e9es (13%). 12 des 33 patients ont du \u00eatre hospitalis\u00e9s. Toutes les perturbations ont \u00e9t\u00e9 r\u00e9versibles. Le mode d'annonce spontan\u00e9e de complications de la Centrale Suisse des Effets Secondaires des M\u00e9dicaments ne permet pas d'\u00e9valuation de la fr\u00e9quence d'une maladie. Les perturbations neurologiques avec un vaccin contre le FSME semblent cependant rares. Elles sont selon notre exp\u00e9rience r\u00e9versibles. <\/jats:p>","DOI":"10.1024\/0369-8394.91.5.159","type":"journal-article","created":{"date-parts":[[2006,1,31]],"date-time":"2006-01-31T12:03:50Z","timestamp":1138709030000},"page":"159-162","source":"Crossref","is-referenced-by-count":7,"title":["Vermutete neurologische Nebenwirkungen der FSME-Impfung: Erfahrung der Schweizerischen Arzneimittel-Nebenwirkungs-Zentrale (SANZ)"],"prefix":"10.1024","volume":"91","author":[{"family":"Koller Doser","sequence":"first","affiliation":[{"name":"Schweizerische Arzneimittel-Nebenwirkungs-Zentrale (SANZ)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Hartmann","sequence":"additional","affiliation":[{"name":"Schweizerische Arzneimittel-Nebenwirkungs-Zentrale (SANZ)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Fleisch","sequence":"additional","affiliation":[{"name":"Schweizerische Arzneimittel-Nebenwirkungs-Zentrale (SANZ)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Kuhn","sequence":"additional","affiliation":[{"name":"Schweizerische Arzneimittel-Nebenwirkungs-Zentrale (SANZ)"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"101","container-title":["Praxis"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/econtent.hogrefe.com\/doi\/pdf\/10.1024\/0369-8394.91.5.159","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,8]],"date-time":"2022-05-08T11:13:53Z","timestamp":1652008433000},"score":1,"resource":{"primary":{"URL":"https:\/\/econtent.hogrefe.com\/doi\/10.1024\/0369-8394.91.5.159"}},"subtitle":["Suspected Neurological Side-Effects after Tick-Born Encephalitis Vaccination"],"short-title":[],"issued":{"date-parts":[[2002,1,1]]},"references-count":0,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2002,1,1]]}},"alternative-id":["10.1024\/0369-8394.91.5.159"],"URL":"https:\/\/doi.org\/10.1024\/0369-8394.91.5.159","relation":{},"ISSN":["1661-8157","1661-8165"],"issn-type":[{"value":"1661-8157","type":"print"},{"value":"1661-8165","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,1,1]]}}}